United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-103_385f01e9-5b50-41d8-a2d5-748f5f84c027
- Product NDC
- 65162-103
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091124
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (65162-103-03) · 65162-103-03
- 100 CAPSULE in 1 BOTTLE (65162-103-10) · 65162-103-10
- 1000 CAPSULE in 1 BOTTLE (65162-103-11) · 65162-103-11
- 500 CAPSULE in 1 BOTTLE (65162-103-50) · 65162-103-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →